Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
PAVmed Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
PAVM
Nasdaq
3845
https://pavmed.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for PAVmed Inc
PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript
- Mar 28th, 2024 1:47 pm
Q4 2023 PAVmed Inc Earnings Call
- Mar 28th, 2024 6:00 am
PAVmed Full Year 2023 Earnings: EPS Beats Expectations
- Mar 27th, 2024 11:21 am
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
- Mar 26th, 2024 11:32 pm
Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuardĀ® Esophageal Precancer Testing in a Screening Population
- Mar 21st, 2024 1:30 pm
PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX
- Mar 21st, 2024 12:30 pm
Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference
- Mar 20th, 2024 12:30 pm
PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024
- Mar 13th, 2024 12:30 pm
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024
- Mar 12th, 2024 12:30 pm
PAVmed Inc.'s (NASDAQ:PAVM) Intrinsic Value Is Potentially 66% Above Its Share Price
- Feb 29th, 2024 12:23 pm
Lucid Diagnostics Provides Update Regarding World Trade Center Health Program
- Feb 16th, 2024 10:00 pm
Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheckĀ® Esophageal Cell Collection Device during Congressional Testimony
- Feb 15th, 2024 12:45 pm
Lucid Diagnostics Executes Contract to Provide EsoGuardĀ® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors
- Feb 8th, 2024 12:45 pm
What Does PAVmed Inc.'s (NASDAQ:PAVM) Share Price Indicate?
- Jan 18th, 2024 11:20 am
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies
- Dec 12th, 2023 1:30 pm
PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders
- Dec 11th, 2023 2:00 pm
Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential
- Dec 5th, 2023 1:55 pm
PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split
- Dec 4th, 2023 9:20 pm
PAVmed Inc. (NASDAQ:PAVM) Q3 2023 Earnings Call Transcript
- Nov 20th, 2023 5:44 pm
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript
- Nov 16th, 2023 2:07 pm
Scroll